Table 3.
GARS is based on the following genes linked to hypodopaminergia.
| Gene | Polymorphism | Location | Risk Allele | Function Linked to Hypodopaminergia | Reference |
|---|---|---|---|---|---|
| DRD1 | rs4531 or rs4532 | Chr −5 | A | rs4532 is known to reduce the function of the DRD1 gene, which is needed as a “go” drive to activate D1 receptors causing normal dopamine function. | Batel et al. (2008) [15]. |
| DRD2 | rs1800497 | Chr-11 | A | rs1800497 equates functionally to 30–40% lower density of dopamine D2 receptors resulting hypodopaminergic function | Noble et al (1991) [8]. |
| DRD3 | rs6280 | Chr3 | C | Rs6280 in D3 causes an imbalance of the DRD3 function and has assiciated with Heroin Dependence. | Kuo et al. (2014) [16]. |
| DRD4 | 48 base repeat VNTR | Chr 11 exon 3 | Above 7 R | Similar to the D2, the VNTR 7 R and above results in a hypodopaminergia due to lower receptor function. | Van Tol (1998) [17] |
| COMT | rs4680 | Chr 22 | G | Carrying the 9 R allele leads to a high activity of catabolism of dopamine in synapse inducing a hypodopaminergia in the synapse. | Isir et al. (2008) [18] and Wichers et al. [19] |
| OPRM1 | rs1799971 | Chr 6 | G | The G allele is the risk variant of the MOR 118A>G (p.Asn40Asp; SNP rs1799971) promotes a low dopamine function because there will be a lack of inhibition via the GABA inhibitory control of dopamine release at the reward site Nucleus Accumbens (NAc) inducing hypodopaminergia. | Ray et al. (2011) [20] |
| DAT1 | 40 base repeat VNTR | Chr 5 exon 15 | 9R | Carrying the 9 R allele leads to a high activity inducing a hypodopaminergia in the synapse. The DAT1 clears excess dopamine released from the pre-neuron into the synapse and prevents uptake into the receptors on the next neuron. | Byerley et al. (1993) [21]. |
| MOA-A | 30 base repeat VNTR | Chr X Promotor | 3.5 R, 4R | The 3.5 R and 4 R variants are more active than 3 R or 5 R. Excessive amounts of dopamine are broken down in the presynaptic neuron which may result is less dopamine availability for release into the synaptic cleft arriers of the 3.5 and 4 R may display hypodopaminergia (low dopamine function). | Contini et al. (2006) [22]. |
| 5HTTLPR | 43 base repeat INDEL/VNTR plus rs 25531 | Chr 17 | LG, S | The risk variant has 43 base -pair 5″ insertion/deletion, S′ at SNP rs25531. The long allele results in higher serotonin transporter mRNA transcription in human cell lines., The result is that Serotonin is highly reabsorbed from the synapse into the pre-nerve cell causing low serotonin content in the synapse leading to reduced function. | Merenakk et al. (2011) [23] and van der Zwaluw et al. (2010) [24]. |
| GABRB3 | CA repeat DNR | Chr 15 (downstream) | 181 | GABRA3 gene and the risk variant is CA-repeat, whereby allele 181 results in higher activity. This risk allele if overexpressed will cause low dopamine function hypodopaminergia leading to SUD because of inhibition of dopamine release at reward site | Namkoong et al. (2008) [25]. |